Learn More
Thermo Scientific™ Acclaim™ 300 C18 HPLC Columns
Use these wide-pore C18 columns to achieve high-resolution protein separations.
Marca: Thermo Scientific™ 060264
Descrizione
Achieve high-resolution peptide mapping and protein separations with Thermo Scientific™ Acclaim™ 300 C18 LC Columns. The 3μm ultrapure silica particles reduce the limits for diffusion of the analytes into the stationary phase, resulting in fast, high-resolution separations. Compared to 5μm column packings, the smaller particles support increased flow rates and shallower gradients on shorter columns for faster separations.
High-Resolution Separation of Proteins and Peptides- High-performance C18 bonding chemistry on 300Å pore silica
- Application tested for suitability in peptide mapping
- Reproducible for dependable results
- Extremely low bleed, fully compatible with MS
- Stable between pH 2 .5 and 7.5
- Complementary selectivity, high column efficiencies and ultrahigh resolution
- Broad spectrum of stationary phases, including conventional C8 and C18 phases, polar embedded phases and specialty phases including wide-pore
- Performance tested to ensure high quality and reliability
Specifica
Analytical Column | |
1 mL/min. | |
150 mm | |
3 μm | |
300 Å | |
100 m²/g | |
L1 | |
Acclaim | |
8% | |
Yes | |
Glass Lined Tubing | |
Bio-LC |
2.1 mm | |
LC/MS | |
4500 psi (310 bar) | |
2.5 to 7.5 | |
Each | |
60°C | |
C18 | |
Spherical, Fully Porous, Ultrapure Silica | |
Reversed Phase | |
Reversed Phase | |
Analytical Column |
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Limited warranty period: Subject to all warranty requirements and exclusions set out in our Terms and Conditions of Sale, this product is warranted from the date we ship the product and for ninety (90) days thereafter. Disclaimer to internal research use restriction: Any restrictions on the purchaser to utilize the product(s) for internal research purposes only does not apply to the product(s) on the web pages associated with this statement.